Prospective Observational Cohort Study of Transplant and Cell Therapy Candidates and Recipients to Assess Social Determinants of Health
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT06431347
- Status
- Recruiting
Conditions
- Transplant and Cell Therapy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Social Determinants of Health Questionnaire — BEHAVIORALParticipants will also complete a questionnaire about financial barriers to care within the past year, including income bracket and difficulty affording cost-of-living or medical expenses.
Study Details
To learn more about social and financial factors that may influence outcomes of TCT treatment at MD Anderson.
Key Dates
- Start date
- Jun 17, 2024
- Status verified
- Mar 2026
- Primary completion
- Jun 1, 2027
- Completion
- Jun 1, 2029
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: Transplant and Cell Therapy Candidates and RecipientsParticipants that agree to take part in this study, the study staff will first verify your demographic information (such as age, sex, race, and so on). Participants will then be asked about social barriers to care, including but not limited to: * primary language and confidence speaking English * education level * employment history * health literacy * legal history * caregiver status and literacy
Primary Outcome Measure
Social Determinants of Health Questionnaire [ Time Frame: At 6, 12, 18, and 24 months post Transplant and Cell Therapy ]
Central Contacts
- Warren Fingrut, MD(832) 387-8363
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MD Anderson Cancer Center | Houston | Texas | 77030 | Warren Fingrut, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site